912946-93-1

Basic information

• Product Name: 4-(4-methoxycarbonyl-phenoxymethyl)-piperidine-1-carboxylic acid t-butyl ester
• Synonyms: 4-(4-methoxycarbonyl-phenoxymethyl)-piperidine-1-carboxylic acid t-butyl ester
• CAS NO: 912946-93-1
• Molecular Weight: 349.427
• Mol File: 912946-93-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(4-methoxycarbonyl-phenoxymethyl)-piperidine-1-carboxylic acid t-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-methoxycarbonyl-phenoxymethyl)-piperidine-1-carboxylic acid t-butyl ester(912946-93-1)
• EPA Substance Registry System: 4-(4-methoxycarbonyl-phenoxymethyl)-piperidine-1-carboxylic acid t-butyl ester(912946-93-1)

Safety Data

• Hazardous Substances Data: 912946-93-1(Hazardous Substances Data)

Upstream product

• 99-76-3 methyl 4-hydroxylbenzoate 
• 123855-51-6 tert-butyl 4-(hydroxymethyl)piperidin-1-carboxylate 
• 161975-39-9 tert-butyl 4-(((methylsulfonyl)oxy)methyl)piperidine-1-carboxylate 
• 166815-96-9 N-tert-butoxycarbonyl-4-(4-toluenesulphonyloxymethyl)piperidine 

Downstream Products

• 912946-94-2 4-(piperidin-4-ylmethoxy)-methyl benzoate 
• 1035270-79-1 4-[[1-[(2-methylpropan-2-yl)oxycarbonyl]-4-piperidyl]methoxy]benzoic acid 
• 1415574-20-7 methyl 4-[[1-[5-formyl-2-pyridinyl]piperidin-4-yl]methoxy]benzoate 
• 1219963-77-5 4-[[4-(methoxycarbonyl)phenoxy]methyl]piperidine hydrochloride 
• 1252657-77-4 {4-[(4-{[4-(2-tert-Butylphenyl)piperazin-1-yl]carbonyl}phenoxy)methyl]piperidin-1-yl}(oxo)acetic acid 
• 1252657-76-3 Methyl {4-[(4-{[4-(2-tert-butylphenyl)piperazin-1-yl]carbonyl}phenoxy)methyl]piperidin-1-yl}(oxo)acetate 
• 1252655-95-0 1-(2-tert-butylphenyl)-4-{[4-(piperidin-4-ylmethoxy)phenyl]carbonyl}piperazine 
• 1252655-91-6 tert-butyl 4-[(4-{[4-(2-tert-butylphenyl)piperazin-1-yl]carbonyl}phenoxy)methyl]piperidine-1-carboxylate 

Relevant articles and documents

DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES

The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, which has a superior RBP4-lowering action and is useful as a pharmaceutical composition for the prophylaxis or treatment of a disease or condition mediated by an increase in RBP4.

NPY ANTAGONISTS, PREPARATION AND USES

The present invention concerns novel compounds, their preparation and their uses, therapeutic uses in particular. More specifically it concerns derivative compounds having at least two aromatic cycles, their preparation and their uses, in particular in the area of human or animal health. These compounds have an affinity for the biological receptors of neuropeptide Y, NPY, present in the central and peripheral nervous systems. The compounds of the invention are preferably NPY antagonists, and more particularly antagonists of sub-type NPY Y1, and can therefore be used for the therapeutic or prophylactic treatment of any disorder involving NPY. The present invention also concerns pharmaceutical compositions containing said compounds, their preparation and their uses, as well as treatment methods using said compounds.